Fisetin attenuates doxorubicin‐induced cardiotoxicity by inhibiting the insulin‐like growth factor II receptor apoptotic pathway through estrogen receptor‐α/‐β activation

Doxorubicin (DOX), an effective chemotherapeutic drug, has been used to treat various cancers; however, its cardiotoxic side effects restrict its therapeutic efficacy. Fisetin, a flavonoid phytoestrogen derived from a range of fruits and vegetables, has been reported to exert cardioprotective effects against DOX-induced cardiotoxicity; however, the underlying mechanisms remain unclear. This study investigated fisetin's cardioprotective role and mechanism against DOX-induced cardiotoxicity in H9c2 cardiomyoblasts and ovariectomized (OVX) rat models. MTT assay revealed that fisetin treatment noticeably rescued DOX-induced cell death in a dose-dependent manner. Moreover, western blotting and TUNEL-DAPI staining showed that fisetin significantly attenuated DOX-induced cardiotoxicity in vitro and in vivo by inhibiting the insulin-like growth factor II receptor (IGF-IIR) apoptotic pathway through estrogen receptor (ER)-α/-β activation. The echocardiography, biochemical assay, and H&E staining results demonstrated that fisetin reduced DOX-induced cardiotoxicity by alleviating cardiac dysfunction, myocardial injury, oxidative stress, and histopathological damage. These findings imply that fisetin has a significant therapeutic potential against DOX-induced cardiotoxicity.

[1]  Zengwu Wang,et al.  Age at Menarche and Menopause, Reproductive Lifespan, and Risk of Cardiovascular Events Among Chinese Postmenopausal Women: Results From a Large National Representative Cohort Study , 2022, Frontiers in Cardiovascular Medicine.

[2]  Yang Zhang,et al.  Fisetin Attenuates Doxorubicin-Induced Cardiomyopathy In Vivo and In Vitro by Inhibiting Ferroptosis Through SIRT1/Nrf2 Signaling Pathway Activation , 2022, Frontiers in Pharmacology.

[3]  R. Muñoz-Chápuli,et al.  The Insulin-like Growth Factor Signalling Pathway in Cardiac Development and Regeneration , 2021, International journal of molecular sciences.

[4]  A. Anderson,et al.  Early Menopause and Cardiovascular Disease Risk in Women With or Without Type 2 Diabetes: A Pooled Analysis of 9,374 Postmenopausal Women , 2021, Diabetes Care.

[5]  Jai-Sing Yang,et al.  Resveratrol inhibited the metastatic behaviors of cisplatin-resistant human oral cancer cells via phosphorylation of ERK/p-38 and suppression of MMP-2/9. , 2021, Journal of food biochemistry.

[6]  Bei Qin,et al.  Protective effects of fisetin against myocardial ischemia/reperfusion injury , 2020, Experimental and therapeutic medicine.

[7]  Hangyuan Guo,et al.  Dihydromyricetin alleviates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome through activation of SIRT1. , 2020, Biochemical pharmacology.

[8]  F. Azuaje,et al.  Fisetin protects against cardiac cell death through reduction of ROS production and caspases activity , 2020, Scientific Reports.

[9]  Jai-Sing Yang,et al.  Tetramethylpyrazine reverses high-glucose induced hypoxic effects by negatively regulating HIF-1α induced BNIP3 expression to ameliorate H9c2 cardiomyoblast apoptosis , 2020, Nutrition & Metabolism.

[10]  W. Kuo,et al.  The combined inhibition of the CaMKIIδ and calcineurin signaling cascade attenuates IGF‐IIR‐induced cardiac hypertrophy , 2020, Journal of cellular physiology.

[11]  T. Hussain,et al.  The plant flavonoid, fisetin alleviates cigarette smoke-induced oxidative stress, and inflammation in Wistar rat lungs. , 2019, Journal of food biochemistry.

[12]  M. Bin-Jumah,et al.  Fisetin ameliorates oxidative stress, inflammation and apoptosis in diabetic cardiomyopathy , 2019, Life sciences.

[13]  L. Křížová,et al.  Isoflavones , 2019, Molecules.

[14]  Shin-Da Lee,et al.  Combined effects of 17β-estradiol and exercise training on cardiac apoptosis in ovariectomized rats , 2018, PloS one.

[15]  Yan Wang,et al.  Fisetin inhibits cardiac hypertrophy by suppressing oxidative stress. , 2018, The Journal of nutritional biochemistry.

[16]  Syed Shariq Naeem,et al.  Protective effect of syringaldehyde on biomolecular oxidation, inflammation and histopathological alterations in isoproterenol induced cardiotoxicity in rats. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[17]  L. Désaubry,et al.  Updates in Anthracycline-Mediated Cardiotoxicity , 2018, Front. Pharmacol..

[18]  P. Mehta,et al.  Emerging novel drug delivery strategies for bioactive flavonol fisetin in biomedicine. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[19]  L. Cai,et al.  Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 via stimulating the Akt/GSK-3ß/Fyn pathway , 2018, Redox biology.

[20]  Ray-Jade Chen,et al.  Inhibition of HSF2 SUMOylation via MEL18 upregulates IGF-IIR and leads to hypertension-induced cardiac hypertrophy. , 2017, International journal of cardiology.

[21]  Yan-Yan Zhang,et al.  Oxymatrine Ameliorates Doxorubicin-Induced Cardiotoxicity in Rats , 2017, Cellular Physiology and Biochemistry.

[22]  S. Chiang,et al.  Doxorubicin attenuates CHIP-guarded HSF1 nuclear translocation and protein stability to trigger IGF-IIR-dependent cardiomyocyte death , 2016, Cell Death & Disease.

[23]  W. Kuo,et al.  Anthocyanin Attenuates Doxorubicin-Induced Cardiomyotoxicity via Estrogen Receptor-α/β and Stabilizes HSF1 to Inhibit the IGF-IIR Apoptotic Pathway , 2016, International journal of molecular sciences.

[24]  Joshua S. Yuan,et al.  Phytoestrogens and Mycoestrogens Induce Signature Structure Dynamics Changes on Estrogen Receptor α , 2016, International journal of environmental research and public health.

[25]  Shin-Da Lee,et al.  Antiapoptotic effect of exercise training on ovariectomized rat hearts. , 2016, Journal of applied physiology.

[26]  V. Adhami,et al.  Dietary flavonoid fisetin for cancer prevention and treatment. , 2016, Molecular nutrition & food research.

[27]  B. Liu,et al.  Calycosin inhibits oxidative stress-induced cardiomyocyte apoptosis via activating estrogen receptor-α/β. , 2016, Bioorganic & medicinal chemistry letters.

[28]  Y. Kato,et al.  Phytoestrogenic activity of blackcurrant (Ribes nigrum) anthocyanins is mediated through estrogen receptor alpha. , 2015, Molecular nutrition & food research.

[29]  Xiaoming Wang,et al.  SIRT1 protects against myocardial ischemia–reperfusion injury via activating eNOS in diabetic rats , 2015, Cardiovascular Diabetology.

[30]  Wei-Kung Chen,et al.  NFIL3 Suppresses Hypoxia‐induced Apoptotic Cell Death by Targeting the Insulin‐like Growth Factor 2 Receptor , 2015, Journal of cellular biochemistry.

[31]  S. Yip,et al.  Resveratrol protects against doxorubicin‐induced cardiotoxicity in aged hearts through the SIRT1‐USP7 axis , 2015, The Journal of physiology.

[32]  Michael S. Ewer,et al.  Cardiotoxicity of anticancer treatments , 2015, Nature Reviews Cardiology.

[33]  Xuejiao Hou,et al.  Cardioprotective Effects of Total Flavonoids Extracted from Xinjiang Sprig Rosa rugosa against Acute Ischemia/Reperfusion-Induced Myocardial Injury in Isolated Rat Heart , 2015, Cardiovascular Toxicology.

[34]  Yang Ruan,et al.  SIRT1 Functions as an Important Regulator of Estrogen-Mediated Cardiomyocyte Protection in Angiotensin II-Induced Heart Hypertrophy , 2014, Oxidative medicine and cellular longevity.

[35]  Jingting Jiang,et al.  The Role of Kif4A in Doxorubicin-Induced Apoptosis in Breast Cancer Cells , 2014, Molecules and cells.

[36]  M. S. Santos,et al.  Phytoestrogens as alternative hormone replacement therapy in menopause: What is real, what is unknown , 2014, The Journal of Steroid Biochemistry and Molecular Biology.

[37]  W. Kuo,et al.  ANG II promotes IGF-IIR expression and cardiomyocyte apoptosis by inhibiting HSF1 via JNK activation and SIRT1 degradation , 2014, Cell Death and Differentiation.

[38]  L. Guarente,et al.  SIRT1 and other sirtuins in metabolism , 2014, Trends in Endocrinology & Metabolism.

[39]  P. Vejpongsa,et al.  Topoisomerase 2β: A Promising Molecular Target for Primary Prevention of Anthracycline‐Induced Cardiotoxicity , 2013, Clinical pharmacology and therapeutics.

[40]  F. A. Resende,et al.  Evaluation of Estrogenic Potential of Flavonoids Using a Recombinant Yeast Strain and MCF7/BUS Cell Proliferation Assay , 2013, PloS one.

[41]  I. Rahman,et al.  Redox regulation of SIRT1 in inflammation and cellular senescence. , 2013, Free radical biology & medicine.

[42]  F. Tsai,et al.  Danshen mediates through estrogen receptors to activate Akt and inhibit apoptosis effect of Leu27IGF-II-induced IGF-II receptor signaling activation in cardiomyoblasts. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[43]  F. Tsai,et al.  Dung-shen (Codonopsis pilosula) attenuated the cardiac-impaired insulin-like growth factor II receptor pathway on myocardial cells. , 2013, Food chemistry.

[44]  Crispin R Dass,et al.  Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems , 2013, The Journal of pharmacy and pharmacology.

[45]  M. Schaalan,et al.  6-gingerol ameliorated doxorubicin-induced cardiotoxicity: role of nuclear factor kappa B and protein glycation , 2012, Cancer Chemotherapy and Pharmacology.

[46]  U. Schlattner,et al.  Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress. , 2012, Cardiovascular research.

[47]  A. Nudelman,et al.  Activation of DNA damage response pathways as a consequence of anthracycline-DNA adduct formation. , 2012, Biochemical pharmacology.

[48]  H. Crijns,et al.  Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. , 2012, Journal of molecular and cellular cardiology.

[49]  Y. Horio,et al.  Emerging beneficial roles of sirtuins in heart failure , 2012, Basic Research in Cardiology.

[50]  W. Wong,et al.  Fisetin, a bioactive flavonol, attenuates allergic airway inflammation through negative regulation of NF-κB. , 2012, European journal of pharmacology.

[51]  Gui-Bo Sun,et al.  Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro. , 2012, Toxicology.

[52]  Pei-Ming Yang,et al.  Dietary flavonoid fisetin targets caspase-3-deficient human breast cancer MCF-7 cells by induction of caspase-7-associated apoptosis and inhibition of autophagy. , 2011, International journal of oncology.

[53]  N. Sundaresan,et al.  Emerging roles of SIRT1 deacetylase in regulating cardiomyocyte survival and hypertrophy. , 2011, Journal of molecular and cellular cardiology.

[54]  M. Lunder,et al.  Acute Cardioprotective and Cardiotoxic Effects of Bilberry Anthocyanins in Ischemia–Reperfusion Injury: Beyond Concentration-Dependent Antioxidant Activity , 2010, Cardiovascular Toxicology.

[55]  Ramaroson Andriantsitohaina,et al.  Estrogen Receptor Alpha as a Key Target of Red Wine Polyphenols Action on the Endothelium , 2010, PloS one.

[56]  F. Tsai,et al.  Akt mediates 17β-estradiol and/or estrogen receptor-α inhibition of LPS-induced tumor necresis factor-α expression and myocardial cell apoptosis by suppressing the JNK1/2-NFκB pathway , 2009, Journal of cellular and molecular medicine.

[57]  F. Tsai,et al.  Activation of insulin-like growth factor II receptor induces mitochondrial-dependent apoptosis through G(alpha)q and downstream calcineurin signaling in myocardial cells. , 2009, Endocrinology.

[58]  R. Knight,et al.  Targeting STAT1 by myricetin and delphinidin provides efficient protection of the heart from ischemia/reperfusion‐induced injury , 2009, FEBS Letters.

[59]  H. Sies,et al.  How do dietary flavanols improve vascular function? A position paper. , 2008, Archives of biochemistry and biophysics.

[60]  M. Vannan,et al.  Estrogen inhibits cardiac hypertrophy: role of estrogen receptor-beta to inhibit calcineurin. , 2008, Endocrinology.

[61]  N. Narula,et al.  Potentiation of Doxorubicin cardiotoxicity by iron loading in a rodent model. , 2007, Journal of the American College of Cardiology.

[62]  G. Takemura,et al.  Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management. , 2007, Progress in cardiovascular diseases.

[63]  R. Gottlieb,et al.  Bcl-2 family members and apoptosis, taken to heart. , 2007, American journal of physiology. Cell physiology.

[64]  J. Muñoz-Castañeda,et al.  Estradiol and catecholestrogens protect against adriamycin-induced oxidative stress in erythrocytes of ovariectomized rats. , 2006, Toxicology letters.

[65]  V. Godfrey,et al.  CHIP activates HSF1 and confers protection against apoptosis and cellular stress , 2003, The EMBO journal.

[66]  G. Capranico,et al.  Anthracyclines: selected new developments. , 2001, Current medicinal chemistry. Anti-cancer agents.

[67]  Michael Karin,et al.  Is NF‐κB the sensor of oxidative stress? , 1999 .

[68]  P. Queirolo,et al.  Erythropoietin and granulocyte-macrophage colony-stimulating factor allow acceleration and dose escalation of cyclophosphamide/epidoxorubicin/5-fluorouracil chemotherapy: a dose-finding study in patients with advanced breast cancer , 1996, Cancer Chemotherapy and Pharmacology.

[69]  Y. Sun,et al.  A simple method for clinical assay of superoxide dismutase. , 1988, Clinical chemistry.

[70]  J. Doroshow.  Effect of anthracycline antibiotics on oxygen radical formation in rat heart. , 1983, Cancer research.

[71]  J. Sedlák,et al.  Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. , 1968, Analytical biochemistry.

[72]  B. Johnson,et al.  Estimation of product of lipid peroxidation (malonyl dialdehyde) in biochemical systems. , 1966, Analytical biochemistry.